Global Information
회사소개 | 문의 | 비교리스트

세계의 케토롤락 주사제 시장 분석(2021년)

Global Ketorolac Injection Market Research Report 2021

리서치사 QYResearch
발행일 2021년 12월 상품코드 1043169
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 2,900 ₩ 3,733,000 PDF (Single User License)
US $ 4,350 ₩ 5,599,000 PDF (Multi User License)
US $ 5,800 ₩ 7,466,000 PDF (Enterprise Wide License)


세계의 케토롤락 주사제 시장 분석(2021년) Global Ketorolac Injection Market Research Report 2021
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 케토롤락 주사제 시장 규모는 2020년에 9억 6,704만 달러, 2027년 말에는 11억 217만 달러에 이를 것으로 예상됩니다.

또한 2021년부터 2027년간 2.69%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다.

세계의 케토롤락 주사제(Ketorolac Injection) 시장을 분석했으며, 유형별·용도별 시장 동향 전망(2016-2027년), 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 케토롤락 주사제 : 시장 개요

  • 제품 개요와 범위
  • 유형별 내역
    • 판매 성장률 비교 : 유형별(2021-2027년)
    • 15mg/ml
    • 30mg/ml
  • 용도별 내역
    • 판매 비교 : 용도별(2021-2027년)
    • 병원
    • 클리닉
    • 기타
  • 세계의 케토롤락 주사제 시장 규모 : 추정과 예측
    • 세계의 케토롤락 주사제 매출(2016-2027년)
    • 세계의 케토롤락 주사제 판매(2016-2027년)
    • 케토롤락 주사제 시장 규모 : 지역별(2016년/2021년/2027년)

제2장 케토롤락 주사제 : 제조업체별 시장 경쟁

  • 판매·시장 점유율 : 제조업체별(2016-2021년)
  • 매출·시장 점유율 : 제조업체별(2016-2021년)
  • 평균 가격 : 제조업체별(2016-2021년)
  • 케토롤락 주사제 제조업체의 제조거점, 제공 지역, 제품 유형
  • 케토롤락 주사제 시장의 경쟁 상황과 동향
    • 시장 집중률
    • 상위 5개사/10개사의 시장 점유율(매출별)
    • 시장 점유율 : 기업 유형별(Tier 1, Tier 2, Tier 3)
  • 제조업체의 인수합병(M&A) 및 확장 계획

제3장 케토롤락 주사제 시장 : 지역별 과거 시나리오

  • 과거 판매 시나리오 : 지역별(2016-2021년)
  • 과거 매출 시나리오 : 지역별(2016-2021년)
  • 북미 시장 : 국가별 사실과 수치
    • 판매 : 국가별
    • 매출 : 국가별
    • 미국
    • 캐나다
  • 유럽 시장 : 국가별 사실과 수치
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아
  • 아시아태평양 시장 : 지역별 사실과 수치
    • 중국
    • 일본
    • 한국
    • 인도
    • 호주
    • 동남아시아
  • 라틴아메리카 시장 : 국가별 사실과 수치
    • 멕시코
    • 브라질
    • 아르헨티나
  • 중동/아프리카 시장 : 국가별 사실과 수치
    • 터키
    • 사우디아라비아
    • 아랍에미리트(UAE)

제4장 케토롤락 주사제 시장 역사적 분석 : 유형별

  • 판매·시장 점유율 : 유형별(2016-2021년)
  • 매출·시장 점유율 : 유형별(2016-2021년)
  • 가격 : 유형별(2016-2021년)

제5장 케토롤락 주사제 시장 역사적 분석 : 용도별

  • 판매·시장 점유율 : 용도별(2016-2021년)
  • 매출·시장 점유율 : 용도별(2016-2021년)
  • 가격 : 용도별(2016-2021년)

제6장 주요 기업 개요

  • Pfizer
    • 기업 정보
    • 기업 개요와 사업 개요
    • 케토롤락 주사제의 판매·매출·총이익(2016-2021년)
    • 케토롤락 주사제 제품 포트폴리오
    • 최근 동향
  • Fresenius Kabi
  • Fosun Pharma(Gland Pharma)
  • Sagent Pharmaceuticals
  • Hikma
  • Lunan Pharma
  • Alvogen
  • Chengdu Brilliant Pharmaceuticals
  • Athenex
  • Sichuan Medcalo
  • Julphar Bangladesh Ltd.
  • Yung Shin Pharm
  • Tianjin Chase Sun Pharmaceutical
  • ZISKA Pharmaceuticals

제7장 케토롤락 주사제 제조 비용 분석

  • 케토롤락 주사제의 주요 원재료 분석
    • 주요 원재료
    • 원재료 주요 공급업체
  • 제조 비용 구조
  • 케토롤락 주사제 산업 체인 분석

제8장 마케팅 채널, 유통업체, 고객

  • 마케팅 채널
  • 케토롤락 주사제 유통업체 리스트
  • 케토롤락 주사제 고객

제9장 케토롤락 주사제 시장 역학

  • 케토롤락 주사제 업계 동향
  • 케토롤락 주사제 시장 성장 촉진요인
  • 케토롤락 주사제 시장이 해결해야 할 과제
  • 케토롤락 주사제 시장 성장 억제요인

제10장 세계 시장 예측

  • 케토롤락 주사제 시장 : 유형별 추산 및 예측
    • 판매, 예측 : 유형별(2022-2027년)
    • 매출, 예측 : 유형별(2022-2027년)
  • 케토롤락 주사제 시장 : 용도별 추산 및 예측
    • 판매, 예측 : 용도별(2022-2027년)
    • 매출, 예측 : 용도별(2022-2027년)
  • 케토롤락 주사제 시장 : 지역별 추산 및 예측
    • 판매, 예측 : 지역별(2022-2027년)
    • 매출, 예측 : 지역별(2022-2027년)

제11장 분석 결과와 결론

제12장 분석 방법과 데이터 소스

LSH 22.01.24

LIST OF TABLES

  • Table 1. Global Ketorolac Injection Sales (K Units) Growth Rate Comparison by Type (2021-2027)
  • Table 2. Global Ketorolac Injection Sales (K Units) Comparison by Application (2021-2027)
  • Table 3. Global Ketorolac Injection Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
  • Table 4. Key Manufacturers Ketorolac Injection Covered in This Study
  • Table 5. Global Ketorolac Injection Sales (K Units) of Key Manufacturers (2016-2021)
  • Table 6. Global Ketorolac Injection Sales Market Share by Manufacturers (2016-2021)
  • Table 7. Global Ketorolac Injection Revenue (US$ Million) by Manufacturers (2016-2021)
  • Table 8. Global Ketorolac Injection Revenue Share by Manufacturers (2016-2021)
  • Table 9. Global Market Ketorolac Injection Average Price (US$/K Units) of Key Manufacturers (2016-2021)
  • Table 10. Manufacturers Ketorolac Injection Manufacturing Sites and Area Served
  • Table 11. Manufacturers Ketorolac Injection Product Type
  • Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 13. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2020)
  • Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 15. Global Ketorolac Injection Sales by Region (2016-2021) & (K Units)
  • Table 16. Global Ketorolac Injection Sales Market Share by Region (2016-2021)
  • Table 17. Global Ketorolac Injection Revenue by Region (2016-2021) & (US$ Million)
  • Table 18. North America Ketorolac Injection Sales by Country (2016-2021) & (K Units)
  • Table 19. North America Ketorolac Injection Sales Market Share by Country (2016-2021)
  • Table 20. North America Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million)
  • Table 21. North America Ketorolac Injection Revenue Market Share by Country (2016-2021)
  • Table 22. Europe Ketorolac Injection Sales by Country (2016-2021) & (K Units)
  • Table 23. Europe Ketorolac Injection Sales Market Share by Country (2016-2021)
  • Table 24. Europe Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million)
  • Table 25. Europe Ketorolac Injection Revenue Market Share by Country (2016-2021)
  • Table 26. Asia Pacific Ketorolac Injection Sales by Region (2016-2021) & (K Units)
  • Table 27. Asia Pacific Ketorolac Injection Sales Market Share by Region (2016-2021)
  • Table 28. Asia Pacific Ketorolac Injection Revenue by Region (2016-2021) & (US$ Million)
  • Table 29. Asia Pacific Ketorolac Injection Revenue Market Share by Region (2016-2021)
  • Table 30. Latin America Ketorolac Injection Sales by Country (2016-2021) & (K Units)
  • Table 31. Latin America Ketorolac Injection Sales Market Share by Country (2016-2021)
  • Table 32. Latin America Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million)
  • Table 33. Latin America Ketorolac Injection Revenue Market Share by Country (2016-2021)
  • Table 34. Middle East and Africa Ketorolac Injection Sales by Country (2016-2021) & (K Units)
  • Table 35. Middle East and Africa Ketorolac Injection Sales Market Share by Country (2016-2021)
  • Table 36. Middle East and Africa Ketorolac Injection Revenue by Country (2016-2021) & (US$ Million)
  • Table 37. Middle East and Africa Ketorolac Injection Revenue Market Share by Country (2016-2021)
  • Table 38. Global Ketorolac Injection Sales (K Units) by Type (2016-2021)
  • Table 39. Global Ketorolac Injection Sales Market Share by Type (2016-2021)
  • Table 40. Global Ketorolac Injection Revenue (US$ Million) by Type (2016-2021)
  • Table 41. Global Ketorolac Injection Revenue Share by Type (2016-2021)
  • Table 42. Global Ketorolac Injection Price (US$/K Units) by Type (2016-2021)
  • Table 43. Global Ketorolac Injection Sales (K Units) by Application (2016-2021)
  • Table 44. Global Ketorolac Injection Sales Market Share by Application (2016-2021)
  • Table 45. Global Ketorolac Injection Revenue (US$ Million) by Application (2016-2021)
  • Table 46. Global Ketorolac Injection Revenue Share by Application (2016-2021)
  • Table 47. Global Ketorolac Injection Price (US$/K Units) by Application (2016-2021)
  • Table 48. Pfizer Corporation Information
  • Table 49. Pfizer Description and Business Overview
  • Table 50. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 51. Pfizer Recent Developments/Updates
  • Table 52. Fresenius Kabi Corporation Information
  • Table 53. Fresenius Kabi Description and Business Overview
  • Table 54. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 55. Fresenius Kabi Recent Developments/Updates
  • Table 56. Fosun Pharma (Gland Pharma) Corporation Information
  • Table 57. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 58. Fosun Pharma (Gland Pharma) Recent Developments/Updates
  • Table 59. Sagent Pharmaceuticals Corporation Information
  • Table 60. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 61. Sagent Pharmaceuticals Recent Developments/Updates
  • Table 62. Hikma Corporation Information
  • Table 63. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 64. Hikma Recent Developments/Updates
  • Table 65. Lunan Pharma Corporation Information
  • Table 66. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 67. Alvogen Corporation Information
  • Table 68. Alvogen Description and Business Overview
  • Table 69. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 70. Alvogen Recent Developments/Updates
  • Table 71. Chengdu Brilliant Pharmaceuticals Corporation Information
  • Table 72. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 73. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
  • Table 74. Athenex Corporation Information
  • Table 75. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 76. Athenex Recent Developments/Updates
  • Table 77. Sichuan Medcalo Corporation Information
  • Table 78. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 79. Sichuan Medcalo Recent Developments/Updates
  • Table 80. Julphar Bangladesh Ltd. Corporation Information
  • Table 81. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 82. Yung Shin Pharm Corporation Information
  • Table 83. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 84. Yung Shin Pharm Recent Developments/Updates
  • Table 85. Tianjin Chase Sun Pharmaceutical Corporation Information
  • Table 86. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 87. Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
  • Table 88. ZISKA Pharmaceuticals Corporation Information
  • Table 89. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
  • Table 90. ZISKA Pharmaceuticals Recent Developments/Updates
  • Table 91. Production Base and Market Concentration Rate of Raw Material
  • Table 92. Key Suppliers of Raw Materials
  • Table 93. Ketorolac Injection Distributors List
  • Table 94. Ketorolac Injection Customers List
  • Table 95. Ketorolac Injection Market Trends
  • Table 96. Ketorolac Injection Growth Drivers
  • Table 97. Ketorolac Injection Market Challenges
  • Table 98. Ketorolac Injection Market Restraints
  • Table 99. Global Ketorolac Injection Sales Forecast by Type (2022-2027) & (K Units)
  • Table 100. Global Ketorolac Injection Sales Market Share Forecast by Type (2022-2027)
  • Table 101. Global Ketorolac Injection Revenue Forecast by Type (2022-2027) & (US$ Million)
  • Table 102. Global Ketorolac Injection Revenue Market Share Forecast by Type (2022-2027)
  • Table 103. Global Ketorolac Injection Sales Forecast by Application (2022-2027) & (K Units)
  • Table 104. Global Ketorolac Injection Sales Market Share Forecast by Application (2022-2027)
  • Table 105. Global Ketorolac Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
  • Table 106. Global Ketorolac Injection Revenue Market Share Forecast by Application (2022-2027)
  • Table 107. Global Ketorolac Injection Sales Forecast by Region (2022-2027) & (K Units)
  • Table 108. Global Ketorolac Injection Sales Market Share Forecast by Region (2022-2027)
  • Table 109. Global Ketorolac Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
  • Table 110. Global Ketorolac Injection Revenue Market Share Forecast by Region (2022-2027)
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Product Picture of Ketorolac Injection
  • Figure 2. Global Ketorolac Injection Market Share by Type in 2020 & 2027
  • Figure 3. 15mg/ml Product Picture
  • Figure 4. 30mg/ml Product Picture
  • Figure 5. Global Ketorolac Injection Market Share by Application in 2020 & 2027
  • Figure 6. Hospital
  • Figure 7. Clinics
  • Figure 8. Others
  • Figure 9. Global Ketorolac Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 10. Global Ketorolac Injection Market Size 2016-2027 (US$ Million)
  • Figure 11. Global Ketorolac Injection Sales 2016-2027 (K Units)
  • Figure 12. Global Ketorolac Injection Market Size by Region: 2016 VS 2021 VS 2027
  • Figure 13. Ketorolac Injection Sales Share by Manufacturers in 2020
  • Figure 14. Global Ketorolac Injection Revenue Share by Manufacturers in 2020
  • Figure 15. Global 5 and 10 Largest Ketorolac Injection Players: Market Share by Revenue in Ketorolac Injection in 2020
  • Figure 16. Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
  • Figure 17. Global Ketorolac Injection Sales Market Share by Region (2016-2021)
  • Figure 18. Global Ketorolac Injection Sales Market Share by Region in 2020
  • Figure 19. Global Ketorolac Injection Revenue Market Share by Region (2016-2021)
  • Figure 20. Global Ketorolac Injection Revenue Market Share by Region in 2020
  • Figure 21. North America Ketorolac Injection Sales Market Share by Country in 2020
  • Figure 22. U.S. Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 23. Canada Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 24. Germany Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 25. France Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 26. U.K. Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 27. Italy Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 28. Russia Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 29. China Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 30. Japan Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 31. South Korea Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 32. India Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 33. Australia Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 34. Southeast Asia Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 35. Mexico Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 36. Brazil Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 37. Argentina Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 38. Turkey Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 39. Saudi Arabia Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 40. UAE Ketorolac Injection Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 41. Sales Market Share of Ketorolac Injection by Type (2016-2021)
  • Figure 42. Sales Market Share of Ketorolac Injection by Application (2016-2021)
  • Figure 43. Sales Market Share of Ketorolac Injection by Application in 2020
  • Figure 44. Revenue Share of Ketorolac Injection by Application (2016-2021)
  • Figure 45. Revenue Market Share of Ketorolac Injection by Application in 2020
  • Figure 46. Pfizer Ketorolac Injection Product
  • Figure 47. Fresenius Kabi Ketorolac Injection Product
  • Figure 48. Fosun Pharma (Gland Pharma) Ketorolac Injection Product
  • Figure 49. Sagent Pharmaceuticals Ketorolac Injection Product
  • Figure 50. Hikma Ketorolac Injection Product
  • Figure 51. Lunan Pharma Ketorolac Injection Product
  • Figure 52. Alvogen Ketorolac Injection Product
  • Figure 53. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product
  • Figure 54. Athenex Ketorolac Injection Product
  • Figure 55. Sichuan Medcalo Ketorolac Injection Product
  • Figure 56. Julphar Bangladesh Ltd. Ketorolac Injection Product
  • Figure 57. Yung Shin Pharm Ketorolac Injection Product
  • Figure 58. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product
  • Figure 59. ZISKA Pharmaceuticals Ketorolac Injection Product
  • Figure 60. Manufacturing Cost Structure of Ketorolac Injection
  • Figure 61. Ketorolac Injection Industrial Chain Analysis
  • Figure 62. Channels of Distribution
  • Figure 63. Distributors Profiles
  • Figure 64. Bottom-up and Top-down Approaches for This Report
  • Figure 65. Data Triangulation
  • Figure 66. Key Executives Interviewed 93

The global Ketorolac Injection market was valued at US$ 967.04 million in 2020 and is expected to reach US$ 1102.17 million by the end of 2027, growing at a CAGR of 2.69% during 2021-2027.

This report focuses on Ketorolac Injection volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ketorolac Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, India, etc.

Segment Analysis:

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • Pfizer
  • Fresenius Kabi
  • Fosun Pharma (Gland Pharma)
  • Sagent Pharmaceuticals
  • Hikma
  • Lunan Pharm
  • Alvogen
  • Chengdu Brilliant Pharmaceuticals
  • Athenex
  • Sichuan Medcalo
  • Julphar Bangladesh Ltd.
  • Yung Shin Pharm
  • Tianjin Chase Sun Pharmaceutical
  • ZISKA Pharmaceuticalshin Pharm

Segment by Type

  • 15mg/ml
  • 30mg/ml

Segment by Application

  • Hospital
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

TABLE OF CONTENTS

1 KETOROLAC INJECTION MARKET OVERVIEW

  • 1.1 Product Overview and Scope of Ketorolac Injection
  • 1.2 Ketorolac Injection Segment by Type
    • 1.2.1 Global Ketorolac Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 15mg/ml
    • 1.2.3 30mg/ml
  • 1.3 Ketorolac Injection Segment by Application
    • 1.3.1 Global Ketorolac Injection Sales Comparison by Application (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinics
    • 1.3.4 Others
  • 1.4 Global Ketorolac Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Ketorolac Injection Revenue 2016-2027
    • 1.4.2 Global Ketorolac Injection Sales 2016-2027
    • 1.4.3 Ketorolac Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 KETOROLAC INJECTION MARKET COMPETITION BY MANUFACTURERS

  • 2.1 Global Ketorolac Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Ketorolac Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Ketorolac Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Ketorolac Injection Market Competitive Situation and Trends
    • 2.5.1 Ketorolac Injection Market Concentration Rate
    • 2.5.2 The Global 5 and 10 Largest Ketorolac Injection Players Market Share by Revenue
    • 2.5.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 KETOROLAC INJECTION RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 Global Ketorolac Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Ketorolac Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Ketorolac Injection Market Facts & Figures by Country
    • 3.3.1 North America Ketorolac Injection Sales by Country
    • 3.3.2 North America Ketorolac Injection Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Ketorolac Injection Market Facts & Figures by Country
    • 3.4.1 Europe Ketorolac Injection Sales by Country
    • 3.4.2 Europe Ketorolac Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Ketorolac Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Ketorolac Injection Sales by Region
    • 3.5.2 Asia Pacific Ketorolac Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Southeast Asia
  • 3.6 Latin America Ketorolac Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Ketorolac Injection Sales by Country
    • 3.6.2 Latin America Ketorolac Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Ketorolac Injection Sales by Country
    • 3.7.2 Middle East and Africa Ketorolac Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 KETOROLAC INJECTION HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 Global Ketorolac Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Ketorolac Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Ketorolac Injection Price by Type (2016-2021)

5 KETOROLAC INJECTION HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 Global Ketorolac Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Ketorolac Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Ketorolac Injection Price by Application (2016-2021)

6 KEY COMPANIES PROFILED

  • 6.1 Pfizer
    • 6.1.1 Pfizer Corporation Information
    • 6.1.2 Pfizer Description and Business Overview
    • 6.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Pfizer Ketorolac Injection Product Portfolio
    • 6.1.5 Pfizer Recent Developments/Updates
  • 6.2 Fresenius Kabi
    • 6.2.1 Fresenius Kabi Corporation Information
    • 6.2.2 Fresenius Kabi Description and Business Overview
    • 6.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
    • 6.2.5 Fresenius Kabi Recent Developments/Updates
  • 6.3 Fosun Pharma (Gland Pharma)
    • 6.3.1 Fosun Pharma (Gland Pharma) Corporation Information
    • 6.3.2 Fosun Pharma (Gland Pharma) Description and Business Overview
    • 6.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
    • 6.3.5 Fosun Pharma (Gland Pharma) Recent Developments/Updates
  • 6.4 Sagent Pharmaceuticals
    • 6.4.1 Sagent Pharmaceuticals Corporation Information
    • 6.4.2 Sagent Pharmaceuticals Description and Business Overview
    • 6.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
    • 6.4.5 Sagent Pharmaceuticals Recent Developments/Updates
  • 6.5 Hikma
    • 6.5.1 Hikma Corporation Information
    • 6.5.2 Hikma Description and Business Overview
    • 6.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Hikma Ketorolac Injection Product Portfolio
    • 6.5.5 Hikma Recent Developments/Updates
  • 6.6 Lunan Pharma
    • 6.6.1 Lunan Pharma Corporation Information
    • 6.6.2 Lunan Pharma Description and Business Overview
    • 6.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
  • 6.7 Alvogen
    • 6.7.1 Alvogen Corporation Information
    • 6.7.2 Alvogen Description and Business Overview
    • 6.7.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.7.4 Alvogen Ketorolac Injection Product Portfolio
    • 6.7.5 Alvogen Recent Developments/Updates
  • 6.8 Chengdu Brilliant Pharmaceuticals
    • 6.8.1 Chengdu Brilliant Pharmaceuticals Corporation Information
    • 6.8.2 Chengdu Brilliant Pharmaceuticals Description and Business Overview
    • 6.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
    • 6.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
  • 6.9 Athenex
    • 6.9.1 Athenex Corporation Information
    • 6.9.2 Athenex Description and Business Overview
    • 6.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Athenex Ketorolac Injection Product Portfolio
    • 6.9.5 Athenex Recent Developments/Updates
  • 6.10 Sichuan Medcalo
    • 6.10.1 Sichuan Medcalo Corporation Information
    • 6.10.2 Sichuan Medcalo Description and Business Overview
    • 6.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
    • 6.10.5 Sichuan Medcalo Recent Developments/Updates
  • 6.11 Julphar Bangladesh Ltd.
    • 6.11.1 Julphar Bangladesh Ltd. Corporation Information
    • 6.11.2 Julphar Bangladesh Ltd. Description and Business Overview
    • 6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
  • 6.12 Yung Shin Pharm
    • 6.12.1 Yung Shin Pharm Corporation Information
    • 6.12.2 Yung Shin Pharm Description and Business Overview
    • 6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
    • 6.12.5 Yung Shin Pharm Recent Developments/Updates
  • 6.13 Tianjin Chase Sun Pharmaceutical
    • 6.13.1 Tianjin Chase Sun Pharmaceutical Corporation Information
    • 6.13.2 Tianjin Chase Sun Pharmaceutical Description and Business Overview
    • 6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
    • 6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
  • 6.14 ZISKA Pharmaceuticals
    • 6.14.1 ZISKA Pharmaceuticals Corporation Information
    • 6.14.2 ZISKA Pharmaceuticals Description and Business Overview
    • 6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
    • 6.14.5 ZISKA Pharmaceuticals Recent Developments/Updates

7 KETOROLAC INJECTION MANUFACTURING COST ANALYSIS

  • 7.1 Ketorolac Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Ketorolac Injection Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 8.1 Marketing Channel
  • 8.2 Ketorolac Injection Distributors List
  • 8.3 Ketorolac Injection Customers

9 KETOROLAC INJECTION MARKET DYNAMICS

  • 9.1 Ketorolac Injection Industry Trends
  • 9.2 Ketorolac Injection Growth Drivers
  • 9.3 Ketorolac Injection Market Challenges
  • 9.4 Ketorolac Injection Market Restraints

10 GLOBAL MARKET FORECAST

  • 10.1 Ketorolac Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Ketorolac Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Ketorolac Injection by Type (2022-2027)
  • 10.2 Ketorolac Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Ketorolac Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Ketorolac Injection by Application (2022-2027)
  • 10.3 Ketorolac Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Ketorolac Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Ketorolac Injection by Region (2022-2027)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 Methodology/Research Approach
    • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
  • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
  • 12.3 Author List
  • 12.4 Disclaimer 94
Back to Top
전화 문의
F A Q